AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Medica

Share Issue/Capital Change Dec 12, 2025

4116_rns_2025-12-12_e892efb5-2efa-4dab-9730-a96bddca16e7.pdf

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

.1

Data/Ora Ricezione : 12 Dicembre 2025 08:12:15

Oggetto : FINAL COMMUNICATION OF THE

STABILIZATION ACTIVITY AND EXERCISE

OF THE GREENSHOE OPTION

Testo del comunicato

Vedi allegato

FINAL COMMUNICATION OF THE STABILIZATION ACTIVITY AND EXERCISE OF THE GREENSHOE OPTION

Castronno (VA), 11 December 2025 - Più Medical S.p.A. ("Più Medical" or the "Company"), consolidation platform with a buy-fix-scale model active in the retail pharmacy sector and focused, as of the date of this press release, on the Lombardy region – announces that today Banca Investis S.p.A. ("Investis"), acting as stabilisation agent, also on behalf of the Joint Bookrunners, has partially exercised the Greenshoe Option granted by shareholders G.S.M. S.r.l. and La Farmaceutica S.p.A. (collectively, the "Selling Shareholders") for a total of 204.500 ordinary shares of the Company (the "Shares").

The Greenshoe Option was exercised at a price of €6,00 per share, equal to the price of the placement prior to Più Medical's IPO, for a total value of €1.227.000. Taking into account the exercise of the Greenshoe Option, the free float now amounts to 20,22% of the share capital and 13,75% of the voting rights.

Payment for the Shares subject to the Greenshoe option and the return to the Selling Shareholders of the 70.500 Shares loaned pursuant to the Over-allotment option will take place on December 16, 2025.

Following the exercise of the Greenshoe Option, the offering therefore involved 2.154.500 ordinary shares (of which 1.700.000 were newly issued), for a total value of €12,9 million.

The following table shows the composition of Più Medical's share capital as of today's date, following the exercise of the Greenshoe Option, indicating the number of shares held by shareholders, the relevant category, and the respective percentage of total share capital and total voting rights:

Shareholders n. Ordinary
shares
n. Multiple voting
shares
% of share
capital
% of voting
rights
G.S.M. S.r.l. 3.115.228 259.881 50,37% 58,01%
La Farmaceutica S.p.A. 280.272 90.119 5,53% 12,00%
V.F. Pharma S.r.l. 1.600.000 - 23,88% 16,24%
Mercato 1.354.500 - 20,22% 13,75%
TOTAL 6.350.000 350.000 100% 100%

The stabilization period ends immediately upon exercise of the Greenshoe Option.

Più Medical, based on information provided by Banca Investis S.p.A. in its capacity as the entity responsible for stabilization activities in connection with the offering of Più Medical ordinary shares on Euronext Growth Milan - announces that Investis has carried out stabilization transactions (as defined in Article 3, paragraph 2, letter d) of the Market Abuse Regulation (EU/596/2014) in relation to the offering of financial instruments described below.

piumedical.com

Issuer: Più Medical S.p.A.
Financial instruments Ordinary Shares ISIN IT0005676140
Offering size 1.950.000
Total number of shares subject to stabilization 275.000
Entity in charge of the stabilization activities Banca Investis S.p.A.

Pursuant to Article 6, paragraph 2 of Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No. 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards on the conditions applicable to share buy-back programs and stabilization measures, Più Medical, based on information provided by Investis, announces that stabilization activities began on November 20, 2025, and that the last stabilization operation took place on [December 9, 2025].

The following table shows the data relating to the transactions carried out during the stabilization period.

Stabilization transactions

Date Total number of
ordinary shares
Number of
transactions
Price range (EUR) Trading venue
20/11/2025 17.000 13 5,74 –
5,84
Borsa Italiana -
Euronext
Growth Milan
21/11/2025 14.000 17 5,76 –
5,94
Borsa Italiana -
Euronext
Growth Milan
24/11/2025 10.250 18 5,87 –
5,95
Borsa Italiana -
Euronext
Growth Milan
25/11/2025 6.000 10 5,93 –
5,95
Borsa Italiana -
Euronext
Growth Milan
27/11/2025 2.250 3 5,85 –
5,94
Borsa Italiana -
Euronext
Growth Milan
28/11/2025 2.250 5 5,90 –
5,90
Borsa Italiana -
Euronext
Growth Milan
01/12/2025 2.500 5 5,93 –
5,95
Borsa Italiana -
Euronext
Growth Milan
02/12/2025 3.250 7 5,90 –
5,95
Borsa Italiana -
Euronext
Growth Milan

piumedical.com

03/12/2025 1.750 4 5,89 –
5,90
Borsa Italiana -
Euronext
Growth Milan
04/12/2025 2.250 5 5,88 –
5,90
Borsa Italiana -
Euronext
Growth Milan
05/12/2025 2,250 5 5.9 –
5.95
Borsa Italiana -
Euronext
Growth Milan
08/12/2025 500 1 5.901 Borsa Italiana -
Euronext
Growth Milan
09/12/2025 500 1 5.95 Borsa Italiana -
Euronext
Growth Milan

This press release is also issued on behalf of Banca Investis pursuant to Article 6(2) of Delegated Regulation (EU) 2016/1052.

For further information on Più Medical and the initial offering, please refer to the Admission Document published on November 18, 2025. The Admission Document is available on the website www.piumedical.com, in the "Investor Relations/IPO EGM" section.

The press release is available on the Company's website www.piumedical.com, in the "Investor Relations/Press Releases" section and at .

***

For the transmission and storage of Regulated Information, Più Medical uses the authorized SDIR eMarket Storage circuit (), managed by Teleborsa S.r.l. - with headquarters in Piazza di Priscilla, 4 - Rome.

CONTACTS

Fabio Luigi Giordano Value track SIM S.p.A. Viale Lombardia 62, 21040 Castronno (VA) Via Masaccio 172/174, Firenze +39 0332 896059 [email protected] [email protected]

Banca Investis S.p.A. Twister Communications Group Via Broletto, 5, 20121 Milano Via Valparaiso, 3 - 20144 Milano + 39 0299968127 Tel. +39 02438114200

Investor Relator Euronext Growth Advisor

Specialist MEDIA RELATIONS

[email protected] Lucia Saluzzi, Luca Di Bitetto [email protected]

Più Medical S.p.A.

Viale Lombardia 62 – 21040 Castronno (VA) Tel. +39 0332.896050

P. Iva e C.F. 04088410123

piumedical.com

The Company

Più Medical is a consolidation platform with a buy-fix-scale model, established in 2025 and focused on the retail pharmacy sector in Northern Italy. The Group currently manages a network of 16 pharmacies. The Group's activity focuses on the management and enhancement of local pharmacies through a centralized operating model that integrates industrial, managerial, and commercial expertise. Più Medical is characterized by an approach geared towards efficiency and profitability, based on structured processes, economies of scale, and a governance model capable of supporting future growth.

Talk to a Data Expert

Have a question? We'll get back to you promptly.